Drugs / 68Ga-Pentixather
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT05364177 | Aug 2021 → Aug 2024 | plasma cell myeloma | Peking Union Medical College Hospital | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 68Ga-Pentixather | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05364177 ↗ |
| Modality | Diagnostic / imaging agent | “68Ga-pentixather PET/CT” NCT05364177 ↗ |
| Route | Intravenous | “After intravenous injection of 68Ga-pentixather, PET/CT scan will be performed.” NCT05364177 ↗ |